SPRY

ARS PHARMACEUTICALS INC

SPRY·82835W108·US·Common Stock·Healthcare - Biotechnology-Activist

SPRY (ARS PHARMACEUTICALS INC) is held by 105 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($87.2M), MILLENNIUM MANAGEMENT LLC ($48M), BlackRock, Inc. ($40.2M). Net institutional sentiment: Mixed.

105
Holders
Avg rating(23 Elite)
$425.1M
Total Value
51% (114)
Fund Consensus
52 buying - 49 selling
SPRYSmart Money Verdict
View all
Held by 105 funds
23 elite
Who's Trading
ActivistMillennium Management LLCMillennium Management LLC2.5%Jul 14, 2026
ActivistRURubric Capital Management LP8.1%May 15, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.0%Apr 27, 2026
ActivistIntegrated Core Strategies (US) LLCIntegrated Core Strategies (US) LLC5.2%Mar 31, 2026
InsiderDBDorsey BrianSell $190KNov 13, 2025
InsiderCJChakma JustinSell $267KNov 12, 2025
InsiderCJChakma JustinSell $1.2MNov 12, 2025
ActivistRA Capital Management, L.P.RA Capital Management, L.P.11.1%Oct 1, 2025
InsiderLELowenthal Richard ESell $724KAug 21, 2025
InsiderSDScott Kathleen D.Sell $188KAug 21, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
10.9M$87.2M0.9%+33.96%
0
Increased
6M(+88.8%)$48M0.0%-23.19%
46
Decreased
5M(-1.4%)$40.2M0.0%-26.37%
0
Increased
4.1M(+15.7%)$33M0.1%-31.11%
33
Increased
3.6M(+13.1%)$29.3M0.0%-20.83%
32
Increased
3.3M(+28.9%)$26.3M0.0%+24.96%
36
New
2.5M$20.4M0.0%-10.48%
39
Increased
2.3M(+2.2%)$18.2M0.0%-33.90%
29
Decreased
1.8M(-9.3%)$14.2M0.0%-46.81%
0
Decreased
1.5M(-1.7%)$12.3M0.0%-24.65%
0
Increased
1.3M(+0.4%)$10.2M0.0%-20.47%
28
Increased
1M(+79.8%)$8M0.4%-23.73%
51
Decreased
724,219(-10.8%)$5.8M0.0%-45.18%
0
Decreased
533,394(-3.2%)$4.3M0.0%+11.49%
0
Increased
529,284(+1.6%)$4.3M0.0%-30.71%
27
Decreased
525,224(-7.2%)$4.2M0.0%-25.92%
0
New
510,551$4.1M0.0%-10.48%
37
Increased
464,681(+52.6%)$3.7M0.0%-34.20%
37
Decreased
455,575(-43.8%)$3.7M0.0%-31.79%
0
New
446,307$3.6M0.0%-10.48%
37

Showing 1-20 of 114

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used